Transplacental treatment of foetal supraventricular tachycardia with triple antiarrhythmic combination to avoid intra-foetal intervention
Keyword(s):
Abstract Although a high percentage of foetuses with supraventricular tachycardia respond to single or dual antiarrhythmic therapy, on occasion when there is no response to these combination regimens, direct intra-foetal therapy remains the only choice, albeit such an approach carries a potential risk to the foetus. Data with regard to the safety and efficacy of triple antiarrhythmic combination have not been reported before. Here, we present a foetus with intractable tachycardia in whom arrhythmia termination was successfully achieved with triple oral antiarrhythmic therapy.
2018 ◽
Vol 28
(4)
◽
pp. 502-508
◽
1985 ◽
Vol 56
(10)
◽
pp. 593-597
◽
2002 ◽
Vol 12
(5)
◽
pp. 494-495
◽